Literature DB >> 27075102

The tumour trail left in blood.

Kelly Rae Chi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27075102     DOI: 10.1038/532269a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

Authors:  Isaac Garcia-Murillas; Gaia Schiavon; Britta Weigelt; Charlotte Ng; Sarah Hrebien; Rosalind J Cutts; Maggie Cheang; Peter Osin; Ashutosh Nerurkar; Iwanka Kozarewa; Javier Armisen Garrido; Mitch Dowsett; Jorge S Reis-Filho; Ian E Smith; Nicholas C Turner
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

2.  Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor.

Authors:  Hyungsoon Im; Huilin Shao; Yong Il Park; Vanessa M Peterson; Cesar M Castro; Ralph Weissleder; Hakho Lee
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

3.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

4.  Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.

Authors:  Matthew W Snyder; Martin Kircher; Andrew J Hill; Riza M Daza; Jay Shendure
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

5.  Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.

Authors:  Gregory A Chang; Jyothirmayee S Tadepalli; Yongzhao Shao; Yilong Zhang; Sarah Weiss; Eric Robinson; Cindy Spittle; Manohar Furtado; Dawne N Shelton; George Karlin-Neumann; Anna Pavlick; Iman Osman; David Polsky
Journal:  Mol Oncol       Date:  2015-09-25       Impact factor: 6.603

6.  Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.

Authors:  Eleonor Olsson; Christof Winter; Anthony George; Yilun Chen; Jillian Howlin; Man-Hung Eric Tang; Malin Dahlgren; Ralph Schulz; Dorthe Grabau; Danielle van Westen; Mårten Fernö; Christian Ingvar; Carsten Rose; Pär-Ola Bendahl; Lisa Rydén; Åke Borg; Sofia K Gruvberger-Saal; Helena Jernström; Lao H Saal
Journal:  EMBO Mol Med       Date:  2015-08       Impact factor: 12.137

7.  Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

Authors:  Jens G Lohr; Viktor A Adalsteinsson; Kristian Cibulskis; Atish D Choudhury; Mara Rosenberg; Peter Cruz-Gordillo; Joshua M Francis; Cheng-Zhong Zhang; Alex K Shalek; Rahul Satija; John J Trombetta; Diana Lu; Naren Tallapragada; Narmin Tahirova; Sora Kim; Brendan Blumenstiel; Carrie Sougnez; Alarice Lowe; Bang Wong; Daniel Auclair; Eliezer M Van Allen; Mari Nakabayashi; Rosina T Lis; Gwo-Shu M Lee; Tiantian Li; Matthew S Chabot; Amy Ly; Mary-Ellen Taplin; Thomas E Clancy; Massimo Loda; Aviv Regev; Matthew Meyerson; William C Hahn; Philip W Kantoff; Todd R Golub; Gad Getz; Jesse S Boehm; J Christopher Love
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

8.  Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

Authors:  Jeffrey B Smerage; William E Barlow; Gabriel N Hortobagyi; Eric P Winer; Brian Leyland-Jones; Gordan Srkalovic; Sheela Tejwani; Anne F Schott; Mark A O'Rourke; Danika L Lew; Gerald V Doyle; Julie R Gralow; Robert B Livingston; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 50.717

  8 in total
  23 in total

Review 1.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

Review 2.  The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.

Authors:  Jérôme Alexandre Denis; Erell Guillerm; Florence Coulet; Annette K Larsen; Jean-Marc Lacorte
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

3.  Isolation and Characterization of Microvesicles from Peripheral Blood.

Authors:  Kerstin Menck; Annalen Bleckmann; Matthias Schulz; Lena Ries; Claudia Binder
Journal:  J Vis Exp       Date:  2017-01-06       Impact factor: 1.355

Review 4.  Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosis.

Authors:  Long Chen; Yu Chen; Yuan-Ling Feng; Yan Zhu; Li-Quan Wang; Shen Hu; Pu Cheng
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 5.  [Personalized oncology].

Authors:  C Heining; P Horak; S Gröschel; H Glimm; S Fröhling
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

Review 6.  Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.

Authors:  Peter Horak; Stefan Fröhling; Hanno Glimm
Journal:  ESMO Open       Date:  2016-11-18

7.  Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma.

Authors:  Jody Vykoukal; Nan Sun; Clemente Aguilar-Bonavides; Hiroyuki Katayama; Ichidai Tanaka; Johannes F Fahrmann; Michela Capello; Junya Fujimoto; Mitzi Aguilar; Ignacio I Wistuba; Ayumu Taguchi; Edwin J Ostrin; Samir M Hanash
Journal:  Oncotarget       Date:  2017-09-08

8.  Magnetic Nanowire Networks for Dual-Isolation and Detection of Tumor-Associated Circulating Biomarkers.

Authors:  HyungJae Lee; Mihye Choi; Jiyun Lim; Minkyung Jo; Ji-Youn Han; Tae Min Kim; Youngnam Cho
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 9.  The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond.

Authors:  Ryan Sullivan; Grace Maresh; Xin Zhang; Carlos Salomon; John Hooper; David Margolin; Li Li
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-08       Impact factor: 5.555

10.  Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour proliferation and promotes apoptosis in Non-small cell lung cancer.

Authors:  Qingqing Zhu; Tangfeng Lv; Ying Wu; Xuefei Shi; Hongbing Liu; Yong Song
Journal:  J Cell Mol Med       Date:  2017-03-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.